全文获取类型
收费全文 | 1687篇 |
免费 | 213篇 |
国内免费 | 2篇 |
出版年
2023年 | 9篇 |
2022年 | 16篇 |
2021年 | 38篇 |
2020年 | 18篇 |
2019年 | 22篇 |
2018年 | 36篇 |
2017年 | 33篇 |
2016年 | 51篇 |
2015年 | 94篇 |
2014年 | 98篇 |
2013年 | 117篇 |
2012年 | 140篇 |
2011年 | 131篇 |
2010年 | 71篇 |
2009年 | 65篇 |
2008年 | 80篇 |
2007年 | 75篇 |
2006年 | 81篇 |
2005年 | 79篇 |
2004年 | 69篇 |
2003年 | 61篇 |
2002年 | 51篇 |
2001年 | 33篇 |
2000年 | 47篇 |
1999年 | 26篇 |
1998年 | 19篇 |
1997年 | 17篇 |
1996年 | 16篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 14篇 |
1992年 | 23篇 |
1991年 | 26篇 |
1990年 | 11篇 |
1989年 | 27篇 |
1988年 | 20篇 |
1987年 | 15篇 |
1986年 | 13篇 |
1985年 | 20篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 9篇 |
1981年 | 10篇 |
1980年 | 6篇 |
1979年 | 10篇 |
1978年 | 15篇 |
1977年 | 8篇 |
1976年 | 5篇 |
1973年 | 7篇 |
1968年 | 4篇 |
排序方式: 共有1902条查询结果,搜索用时 15 毫秒
161.
162.
163.
164.
165.
Lemak A Yee A Bezsonova I Dhe-Paganon S Arrowsmith CH 《Journal of biomolecular NMR》2011,51(1-2):185-190
Ube3A (also referred to as E6AP for E6 Associated Protein) is a E3 ubiquitin-protein ligase implicated in the development of Angelman syndrome by controlling degradation of synaptic protein Arc and oncogenic papilloma virus infection by controlling degradation of p53. This article describe the solution NMR structure of the conserved N-terminal domain of human Ube3A (residues 24-87) that contains two residues (Cys44 and Arg62) found to be mutated in patients with Angelman syndrome. The structure of this domain adopts a novel Zn-binding fold we called AZUL (Amino-terminal Zn-finger of Ube3a Ligase). The AZUL domain has a helix-loop-helix architecture with a Zn ion coordinated by four Cys residues arranged in Cys-X(4)-Cys-X(4)-Cys-X(28)-Cys motif. Three of the Zn-bound residues are located in a 23-residue long and well structured loop that connects two α-helicies. 相似文献
166.
167.
Our recent finding that insulin increased the expression of the glutamate-cysteine ligase catalytic subunit (GCLc) with coincident increases in GCL activity and cellular glutathione (GSH) in human brain microvascular endothelial cells (IHECs) suggests a role for insulin in vascular GSH maintenance. Here, using IHECs stably transfected with promoter-luciferase reporter vectors, we found that insulin increased GCLc promoter activity, which required a prerequisite increase or decrease in medium glucose. An intact antioxidant response element-4 was essential for promoter activation, which was attenuated by inhibitors of PI3-kinase/Akt/mTOR signaling. Interestingly, only under low-glucose conditions did promoter activation correlate with increased GCLc expression and GSH synthesis. Low tert-butylhydroperoxide (tBH) concentrations similarly mediated promoter activation, but the maximal activation dose was decreased 10-fold by insulin. Insulin-tBH coadministration abrogated the low or high glucose requirement for promoter activation, suggesting possible ROS involvement. ROS production was elevated at low glucose without or with insulin; however, GSH increases were not inhibited by tempol, suggesting that ROS did not achieve the threshold for driving GCLc promoter activation and de novo GSH synthesis. The minor effect of pyruvate also ruled out a major role for hypoglycemia (± insulin)-induced metabolic stress on GSH induction under these conditions. 相似文献
168.
169.
Reported previously by our group, we have developed a novel class of antibacterial cationic anthraquinone analogs with superb potency (MIC <1μg/mL) against Gram positive (G+) pathogens including Methicillin-resistant Staphylococcus aureus (MRSA). However, most of these compounds only manifest modest antibacterial activity against Gram negative (G-) bacteria. Further investigation on the antibacterial mode of action using fluorogenic dyes reveals that these compounds exert two different modes of action that account for the difference in their antibacterial profile. It was found that most of the compounds exert their antibacterial activity by disrupting the redox processes of bacteria. At high concentration, these compounds can also act as membrane disrupting agents. This information can help to design new therapeutics against various bacteria. 相似文献
170.
Hum Yan Chai Lai Khin Wee Tan Tian Swee Sh-Hussain Salleh Lim Yee Chea 《Biomedical engineering online》2011,10(1):1-22